Mariners left-hander Robbie Ray will undergo flexor tendon repair surgery, reports Ryan Divish of the Seattle Times. Ray will not be able to return this season. The lefty had already been on the 15-day injured list due to a flexor strain but Divish adds that further testing revealed damage in a different area of the tendon.
The news is obviously terrible for both Ray and the Mariners, as he was a key part of the club’s plans for this year. After an up-and-down career with the Tigers and Diamondbacks, Ray stabilized himself in tremendous fashion with the Blue Jays in 2021. He had always had tremendous strikeout ability but struggled with command, walking 11% of batters he faced in his career by the end of the 2020 campaign. But the 2021 season saw him whittle that down to 6.7% while still getting punchouts at an incredible 32.1% clip. He finished the season with a 2.84 ERA and was awarded the American League Cy Young.
That breakout was perfectly timed, as he went into free agency immediately after, signing a five-year, $115MM deal with the Mariners with an opt-out after the third season. Last year, he naturally regressed from his incredible heights of the year before, but still had a solid year with Seattle. He made 32 starts and posted a 3.71 ERA, striking out 27.4% of opponents while walking 8%. That helped the club break their postseason drought, as they qualified for the playoffs for the first time since 2001. Unfortunately, 2023 season will now go down as a total loss, effectively. Ray made one start of just 3 1/3 innings before landing on the injured list and that will now be his entire tally for the year.
The Mariners have had six viable starters since their deadline acquisition of Luis Castillo last year, which bumped Chris Flexen into the bullpen. With Castillo, Ray, George Kirby, Logan Gilbert and Marco Gonzales set to be in the front five spots, it had been speculated by many that perhaps the club would look to trade Flexen in order to improve another area of the roster. In the end, they kept all six hurlers, a decision which now seems wise in the wake of Ray’s injury. Flexen has struggled so far this year, currently sporting an 8.86 ERA, but was plenty effective for the M’s in the two prior seasons.
This won’t impact the Mariners in the short term as they were already operating without Ray, but this will have a huge impact on their long-term plans now that a return of Ray later in the year is off the table. They have depth options on the 40-man such as Darren McCaughan, José Rodríguez and Easton McGee, but Divish relays word from manager Scott Servais that the club is re-evaluating their pitching depth in the wake of this news. The last time they needed a spot start, veteran journeyman Tommy Milone was given the nod.
Finding external pitching options at this time of the year can be tough as most teams are dealing with injuries of their own and few have decided to press the sell button so early. The free agents that are unsigned are usually still available because they haven’t been effective in a while. That’s certainly the case for Madison Bumgarner, who was just released by the Diamondbacks today, joining pitchers like Dallas Keuchel and Chris Archer on the open market.
The Mariners are currently 11-12 and in fourth place in the American League West, though they are by no means buried with just 2.5 games separating them and the division-leading Rangers. There’s still plenty of time for them to gain ground, but they will now have to do so without any contributions from their player making the highest salary this year.
